131 related articles for article (PubMed ID: 16821707)
21. Antimycobacterial activity of basic ethyl esters of alkoxy-substituted phenylcarbamic acids.
Waisser K; Drazková K; Cizmárik J; Kaustová J
Folia Microbiol (Praha); 2003; 48(1):45-50. PubMed ID: 12744075
[TBL] [Abstract][Full Text] [Related]
22. Prospects for development of new antimycobacterial drugs.
Tomioka H
J Infect Chemother; 2000 Mar; 6(1):8-20. PubMed ID: 11810525
[TBL] [Abstract][Full Text] [Related]
23. N-substituted 2-isonicotinoylhydrazinecarboxamides--new antimycobacterial active molecules.
Rychtarčíková Z; Krátký M; Gazvoda M; Komlóová M; Polanc S; Kočevar M; Stolaříková J; Vinšová J
Molecules; 2014 Mar; 19(4):3851-68. PubMed ID: 24686575
[TBL] [Abstract][Full Text] [Related]
24. Activity of 4,5-dihydro-1H-pyrazoles against Mycobacterium tuberculosis and nontuberculous mycobacteria.
Ramos DF; Fiss G; Frizzo CP; Martins MA; Bonacorso HG; Zanatta N; Almeida da Silva PE
Int J Antimicrob Agents; 2014 May; 43(5):481-3. PubMed ID: 24713182
[No Abstract] [Full Text] [Related]
25. Omadacycline drug susceptibility testing for non-tuberculous mycobacteria using oxyrase to overcome challenges with drug degradation.
Boorgula GD; Gumbo T; Singh S; McShane PJ; Philley JV; Srivastava S
Tuberculosis (Edinb); 2024 Jul; 147():102519. PubMed ID: 38754247
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and antimycobacterial evaluation of N-substituted 3-aminopyrazine-2,5-dicarbonitriles.
Zitko J; Jampílek J; Dobrovolný L; Svobodová M; Kuneš J; Doležal M
Bioorg Med Chem Lett; 2012 Feb; 22(4):1598-601. PubMed ID: 22281187
[TBL] [Abstract][Full Text] [Related]
27. [In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains].
Thomas L; Naumann P; Crea A
Immun Infekt; 1986 Nov; 14(6):203-7. PubMed ID: 3100424
[TBL] [Abstract][Full Text] [Related]
28. In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii.
Gay JD; DeYoung DR; Roberts GD
Antimicrob Agents Chemother; 1984 Jul; 26(1):94-6. PubMed ID: 6236748
[TBL] [Abstract][Full Text] [Related]
29. New rifabutin analogs: synthesis and biological activity against Mycobacterium tuberculosis.
Barluenga J; Aznar F; García AB; Cabal MP; Palacios JJ; Menéndez MA
Bioorg Med Chem Lett; 2006 Nov; 16(22):5717-22. PubMed ID: 16987658
[TBL] [Abstract][Full Text] [Related]
30. New S-benzylisothiosemicarbazones with antimycobacterial activity.
Petrlíková E; Waisser K; Heinisch L; Stolaříková J
Folia Microbiol (Praha); 2011 Jan; 56(1):10-2. PubMed ID: 21394476
[TBL] [Abstract][Full Text] [Related]
31. N1-Hetaryl substituted pyridine- and pyrazinecarboxamidrazones with antimycobacterial activity.
Ranft D; Lehwark-Yvetot G; Schaper KJ; Büge A
Arch Pharm (Weinheim); 1997 Jun; 330(6):169-72. PubMed ID: 9297448
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the Efficacy of Novel Oxazolidinone Analogues against Nontuberculous Mycobacteria In Vitro.
Zhao W; Jiang Y; Bao P; Li Y; Tang L; Zhou Y; Zhao Y
Jpn J Infect Dis; 2015; 68(6):520-2. PubMed ID: 25971324
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria.
Carroll J; Draper LA; O'Connor PM; Coffey A; Hill C; Ross RP; Cotter PD; O'Mahony J
Int J Antimicrob Agents; 2010 Aug; 36(2):132-6. PubMed ID: 20547041
[TBL] [Abstract][Full Text] [Related]
34. In vitro bactericidal activity of oxazolidinone, RBx 8700 against Mycobacterium tuberculosis and Mycobacterium avium complex.
Rao M; Sood R; Malhotra S; Fatma T; Upadhyay DJ; Rattan A
J Chemother; 2006 Apr; 18(2):144-50. PubMed ID: 16736882
[TBL] [Abstract][Full Text] [Related]
35. Use of the BACTEC system for drug susceptibility testing of Mycobacterium tuberculosis, M. kansasii, and M. avium complex.
Steadham JE; Stall SK; Simmank JL
Diagn Microbiol Infect Dis; 1985 Jan; 3(1):33-40. PubMed ID: 3917885
[TBL] [Abstract][Full Text] [Related]
36. Bactericidal activities of povidone-iodine against Mycobacterium.
Rikimaru T; Kondo M; Kondo S; Oizumi K
Dermatology; 1997; 195 Suppl 2():104-6. PubMed ID: 9403266
[TBL] [Abstract][Full Text] [Related]
37. Dibasic Derivatives of Phenylcarbamic Acid against Mycobacterial Strains: Old Drugs and New Tricks?
Malík I; Csöllei J; Solovič I; Pospíšilová Š; Michnová H; Jampílek J; Čížek A; Kapustíková I; Čurillová J; Pecháčová M; Stolaříková J; Pecher D; Oravec M
Molecules; 2018 Sep; 23(10):. PubMed ID: 30274224
[TBL] [Abstract][Full Text] [Related]
38. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
[TBL] [Abstract][Full Text] [Related]
39. N-benzylsalicylthioamides: highly active potential antituberculotics.
Dolezal R; Waisser K; Petrlíková E; Kunes J; Kubicová L; Machácek M; Kaustová J; Dahse HM
Arch Pharm (Weinheim); 2009 Feb; 342(2):113-9. PubMed ID: 19137534
[TBL] [Abstract][Full Text] [Related]
40. Antimycobacterial activity of natural and semi-synthetic lignans.
Silva ML; Martins CH; Lucarini R; Sato DN; Pavanb FR; Freitas NH; Andrade LN; Pereira AC; Bianco TN; Vinholis AH; Cunha WR; Bastos JK; Silva R; Da Silva Filho AA
Z Naturforsch C J Biosci; 2009; 64(11-12):779-84. PubMed ID: 20158145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
